A94-126

Assoc. Prof. Dr. MD.

Hoàng Văn Sỹ

Outpatient Department

Rating:
0/5
(0 rating)
Booking
Rating:
0/5
(0 rating)
Booking
Schedule
TIM MẠCH
  • Sáng thứ bảy
Patient's feeling
0/5
(0 rating)

Write your review

Rating:
Choose rating

Patient rating

No review

Expertise
Internal Medicine
Cardiology
Interventional Cardiology
Arrhythmia
Education
  • 2022: Associate Professor, University Medical Center Ho Chi Minh City
  • 2014: Doctor of Science, Specialist in Internal Cardiology, University Medical Center Ho Chi Minh City
  • 2008: Doctor, Specialist in Cardiology, University Medical Center Ho Chi Minh City
  • 2004: ASF course on cardiology and vascular diseases, France
  • 2000: Resident physician - Level I Specialist in Cardiology, University Medical Center Ho Chi Minh City.
  • 1996: General Practitioner, University Medical Center Ho Chi Minh City
Experience

Teaching experience

  • 2018 - present: Head of General Internal Medicine Department, University Medical Center Ho Chi Minh City
  • 2001 - present: Lecturer in General Internal Medicine, University Medical Center Ho Chi Minh City

Clinical experience

  • 2001 - present: Physician in the Outpatient Department, University of Medicine and Pharmacy Hospital, Ho Chi Minh City
  • 2018 - present: Head of Internal Cardiology Department, Cho Ray Hospital
  • 2015 - 2018: Deputy Head of Interventional Cardiology Department, Cho Ray Hospital
Associations
  • 2022: Vice President of the Vietnamese Heart Failure Subsection
Awards

2025: Outstanding Physician

Research
  • 2025 Tần suất lưu hành đột biến gen LDL-R, APOB và PCSK9 ở bệnh nhân mắc bệnh mạch vành sớm trong định hướng chẩn đoán và điều trị sớm.
  • 2025 Xây dựng mô hình trí tuệ nhân tạo để dự đoán sốc tim ở bệnh nhân nhồi máu cơ tim cấp
  • 2025 Reassessing Cardiovascular Risk Stratification in Vietnam: Insights from SCORE2 and the Original SCORE Model
  • 2025 Lipoprotein(a) in Vietnamese Cardiologists: Findings From a Pilot Study at the Vietnam Atherosclerosis Society Congress
  • 2024 Evaluating Renal Benefits of Rivaroxaban Versus Vitamin K Antagonists in Atrial Fibrillation: A Systematic Review and Meta-analysis of Real-world Evidence